Schematic summarizing the effects of decreased TRPML1 activity on HRASWT and HRASG12V. Our data indicate that TRPML1 inhibition diminished HRASG12V nanoclustering and plasma membrane levels. Addition of cholesterol restored these parameters. Only the nanoclustering of HRASWT was affected by ML-SI1. 